tiprankstipranks
The Fly

Halozyme price target raised to $72 from $70 at H.C. Wainwright

Halozyme price target raised to $72 from $70 at H.C. Wainwright

H.C. Wainwright raised the firm’s price target on Halozyme (HALO) to $72 from $70 and keeps a Buy rating on the shares following the Q4 report. The company reported a sales beat driven by a jump in royalty revenues, the analyst tells investors in a research note. The firm says the Enhanze business “remains the crux” of its investment thesis.

Discover the Best Stocks and Maximize Your Portfolio:

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1